FDA product code · Gastroenterology, Urology · Class 2

FCG: Biopsy Needle

FCG is FDA's product code for "Biopsy Needle": a Class 2 device classified under 21 CFR 876.1075, reviewed by the Gastroenterology, Urology panel.

510(k) review time for FCG

Across 17 510(k) clearances under FCG decided from 2018-01-01 to 2026-10-06, the median was 111 days from FDA receipt to decision. Half took between 90 and 246 days, and 80% were decided within 261 days. These are past clearances, not a forecast for a new submission.

Days from FDA receipt to 510(k) decision, FCG, decisions 2018-01-01 to 2026-10-06 (n = 17)
Fastest59
25th percentile90
Median111
75th percentile246
80th percentile261
90th percentile306
Slowest602

Source: openFDA 510(k) records, snapshot of 2026-10-06 (openFDA data as of 2026-09-28). Compare 510(k) review times across all device types, see every code side by side in the Clearance Timeline Estimator, or browse the clearances themselves in PredicateScope.

FCG in the public FDA record

Records naming FCG, from openFDA (snapshot of 2026-09-15)
510(k) clearances, all years133
Device recalls54
Establishment listings279
GUDID device identifiers1,585

Counts of records, not of devices or events. Adverse event reports for FCG are in MAUDEScope, as counts with the query shown: MAUDE has no denominator, so a report count is not a rate and does not show that a device caused an event.

FDA-recognized standards that cite FCG

No FDA recognized consensus standard cites FCG by product code. Horizontal standards such as biocompatibility, sterilization and software standards can still apply.

Source: FDA Recognized Consensus Standards, snapshot of 2026-09-01. Search them all in the Consensus Standards Lookup.

Related product codes